Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial.
about
New frontiers in obstructive sleep apnoeaDifferential impacts of blood pressure and lipid lowering on regression of ventricular and arterial mass: the Stop Atherosclerosis in Native Diabetics Trial.Associations of edge-detected and manual-traced common carotid intima-media thickness measurements with Framingham risk factors: the multi-ethnic study of atherosclerosis.Carotid intima-media thickness studies: study design and data analysis.Effects of statins on progression of carotid atherosclerosis as measured by carotid intimal--medial thickness: a meta-analysis of randomized controlled trials.Cholesterol, stroke risk, and stroke prevention.Imaging biomarkers of cardiovascular disease.Analysis of a vascular screening program in a rural communityThe antiatherogenic effects of antihypertensive treatment: trials completed and ongoing.Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study.Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trialTreatment of lipid disorders after stroke.Carotid-wall intima-media thickness and cardiovascular eventsSegment-specific associations of carotid intima-media thickness with cardiovascular risk factors: the Coronary Artery Risk Development in Young Adults (CARDIA) study.Emerging, noninvasive surrogate markers of atherosclerosis.Pathophysiology and therapeutic targets for ischemic stroke.Intima-media thickness: indicator of cardiovascular risk and measure of the extent of atherosclerosis.Edge-detected common carotid artery intima-media thickness and incident coronary heart disease in the multi-ethnic study of atherosclerosis.Physical activity and stroke risk.Lipids and stroke: the opportunity of lipid-lowering treatment.Flow-Mediated Vasodilatation and Intima-Media Thickness in Patients with Coexisting Heart Failure and Diabetes Receiving Medical Therapy.Changes in carotid intima-media thickness during the cardiac cycle: the multi-ethnic study of atherosclerosis.Ultrasonic measurement of common carotid intima-media thickness in type 2 diabetic and non-diabetic patients.Variations in common carotid artery intima-media thickness during the cardiac cycle: implications for cardiovascular risk assessment.Imaging Atherosclerosis by Carotid Intima-media Thickness in vivo: How to, Where and in Whom ?Carotid Intima-media Thickness Measurements: Relations with Atherosclerosis, Risk of Cardiovascular Disease and Application in Randomized Controlled TrialsSelf-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)Do statins lower blood pressure?Regression or reduction in progression of atherosclerosis, and avoidance of coronary events, with lovastatin in patients with or at high risk of cardiovascular disease: a review.Risk factor management to prevent first stroke.Is there evidence of early vascular disease in patients with obstructive sleep apnoea without known comorbidities? Preliminary findings.Study of the intima-media thickening in carotid arteries of healthy elderly with high blood pressure and elderly with high blood pressure and dyslipidemiaStatin therapy and carotid endarterectomy: a review of trends in New South Wales, 1990-2004.Attenuation of rate of change in carotid intima-media thickness by lipid-modifying drugs: impact on clinical outcomes.Carotid intima-media thickness and the prediction of vascular events.Is atherosclerosis regression a realistic goal of statin therapy and what does that mean?Evidence that periodontal treatment improves biomarkers and CVD outcomes.Carotid atherosclerotic plaque stenosis: the stabilizing role of statins.Dyslipidemia Part 2: Review of Dyslipidemia Treatment in Patients With Noncoronary Vascular Disease.
P2860
Q26823972-C6D295F3-A29B-4C9F-85D7-C4F1DAEA6073Q30464117-722821FD-15F6-4350-83AB-41A8FB871CD0Q30504091-87D9811F-EDD6-4FF0-B632-740EE7BD5F9CQ30712446-A5A880CA-3073-45FD-BE66-F911D1AE64E9Q33578968-F2DA9953-9AA7-4E14-8D50-E925F2268B5AQ34107346-BB0A8388-CB81-428D-9F37-B0EC6CFE9A81Q34109961-1FEE17D5-B077-4A97-BFC7-674860C87DFEQ34153685-C50903DC-3EE2-479F-9F3B-0D7CDB2246F1Q34317671-1622388D-57E8-4630-842F-963FB6BAEE7BQ34482151-1B66AD8F-61DA-44BD-973E-931601A602A8Q34527201-F1C24488-122A-4D79-B9FB-D6F9484C09FBQ34571157-27597ED2-F3E6-4536-820F-8B76359FFABAQ34674265-C2734798-D4D7-48FD-9A90-9130CE272B81Q35157658-AB68AB75-5D1E-4075-ABED-2A48186823B1Q35185259-2ED2D661-62C6-4132-9857-443A86A93DA6Q35602787-CF7A676E-D129-4363-A7F1-97055583CC97Q35799745-C60D9C5E-1BC5-4A79-BCB1-DC7A6EC9294BQ35824614-9B5F9619-1155-43DE-AAD7-975025FD9474Q36141924-EFB166F5-2A73-44E4-86CD-88AC67EAF276Q36201749-37DA7D93-5D91-40D0-9D64-4F641EB049ABQ36331015-1B4B541B-9B6B-4FC0-9B8C-FBF4B4A7A777Q36334981-66AD416E-FC6A-459E-B569-B042234A3CF5Q36366248-D66DC503-913C-4F20-9698-432D241D2B3BQ36466943-209FEE6E-60D8-447E-AA07-F636D184A490Q36530158-B99F246B-F7A7-4483-A8C0-B415C1DB0BA9Q36568872-363B4981-CF10-477C-8D08-0F4602F8C488Q36705497-331F3B74-4C58-4EA0-A47A-6D8C69191F7EQ36736281-2ACE369B-6BCA-45DC-B7A7-493D6F61DE3FQ36847085-87A7303C-9B55-4D1D-A142-3D7BF4DE6403Q36913015-07EE7B74-762B-4356-BC74-15CCD2B81066Q37153566-1A29A350-0F1A-4F30-BA5D-83AF4C58D511Q37169338-1FEEAC86-4EEC-4A76-BD48-0E04941D6F0CQ37192918-BE063284-5DF8-4C5D-AD6F-29003353C13FQ37536357-B46133F2-C1CF-4D4F-82F5-E681F1E8DD0EQ37886975-E2BF4015-598C-4543-B2E0-4FF42A43DFD3Q38018563-8701BD65-BBD5-48B8-B05C-B81FF82F6D3DQ38068341-B87CD419-8893-49F4-8ACE-F4223ADEB76EQ38102723-2E95FEC0-1F98-416E-8983-CE81ED074D74Q38251322-DA965071-B349-4183-9DDF-291D5D68A6B8Q38777322-E0B37335-5A75-4E65-974F-AE9F9344B633
P2860
Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Reduction in carotid arterial ...... zed controlled clinical trial.
@en
Reduction in carotid arterial ...... zed controlled clinical trial.
@nl
type
label
Reduction in carotid arterial ...... zed controlled clinical trial.
@en
Reduction in carotid arterial ...... zed controlled clinical trial.
@nl
prefLabel
Reduction in carotid arterial ...... zed controlled clinical trial.
@en
Reduction in carotid arterial ...... zed controlled clinical trial.
@nl
P2093
P1476
Reduction in carotid arterial ...... zed controlled clinical trial.
@en
P2093
Alaupovic P
Kwong-Fu H
P304
P356
10.7326/0003-4819-124-6-199603150-00002
P407
P577
1996-03-01T00:00:00Z